ATS 2019 Virtual Final Program

P979 Saddle Pulmonary Embolism in a Patient Post CABG: Successful Treatment with Catheter Thrombectomy/ N.L. Jafar, A. Orenstein, B. Janne d’Othee, Springfield, MA, p.A6779 P980 Have You Seen a Pulmonary Embolus this Big in a Guy this Young? A Case Report/ M. Tahboub, O. Abughanimeh, L. Numan, G. Kumar, M. Younis, A. Bourbia, A. Gohar, Kansas City, MO, p.A6780 P981 Paroxysmal Nocturnal Dyspnea After Atrial Septal Defect Correction: A Case of Pulmonary Hypertension Due to Left Heart Disease/ Q. Jin, Q. Luo, Z. Zhao, Q. Zhao, X. Yu, L. Yan, L. Gao, Z. Liu, Beijing, China, p.A6781 P982 Embolic Stoke Due to Pulmonary Arteriovenous Malformation/ M.F. Khaliq, M. Yasin, A. Nanjundappa, Charleston, WV, p.A6782 P983 An Unlikely Cause of Persistent Hypoglycemia/ C. Leyton, G. Glazman-Kuczaj, C. Reisig, M. Duda, Bronx, NY, p.A6783 P984 Right Heart Dysfunction Secondary to Obesity Hypoventilation Syndrome/ V. Terla, G.L. Rajbhandari, D. Kurian, G.R. Pesola, New York, NY, p.A6784 P985 Severe Right Lower Quadrant Pain: Have You Considered Pulmonary Embolism???/ M. Bilal, A. Umar, E.Y. Chang, M.E. Faquih, B.S. Elhammali, Atlanta, GA, p.A6785 P986 Submassive Venothromboembolism Associated Right Ventricular Dysfunction Resolves After Two Weeks of Anticoagulation with Apixiban/ A. Tawadros, N. Hotchandi, W. Khan, Plainsboro, NJ, p.A6786 P987 Bedside Catheter Directed TPA for Treatment of Acute Massive PE in a High-Risk Super Morbid Obese Patient/ R. Griffith, D. Hernandez, Toledo, OH, p.A6787 P988 Portopulmonary Hypertension: A Case Report with Management Considerations/ S. Randhawa, E. Griffin, M. Dhingra, M. Hiatt, J. Alberts, V.V. Noble, A. Highley, Omaha, NE, p.A6788 P989 Resolution of Pulmonary Arterial Hypertension (PAH) in a Patient with GATA-2 Deficiency Following Bone Marrow Transplant (BMT)/ K. Ryan, N. Shah, S. Holland, K. Olivier, D. Hickstein, H.J. Ford III, N.A. Weir, Bethesda, MD, p.A6789 P990 Carfilzomib-Induced Pulmonary Hypertension: A Rare Complication with Reversal After Discontinuation/ M. Hrustanovic-Kadic, B. Jalil, K. El-Kersh, Louisville, KY, p.A6790 CLINICAL THEMATIC POSTER SESSION D56 X MARKS THE SPOT: NEW BIOMARKERS IN PAH 9:15 a.m. - 3:30 p.m. KBHCCD Area G (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : M.G. Risbano, MD, MA, Pittsburgh, PA P992 Increased Platelet Derived Growth Factor (PDGF) and Bone Morphogenic Protein 4 (BMP4) Levels May Indicate Presence of Combined Pre and Post Capillary WHO Group II Pulmonary Hypertension/ A. Guha, H. Marcos-Abdala, A.S. Cruz-Solbes, J. Amione-Guerra, H. Karmouty-Quintana, Houston, TX, p.A6791 P993 Spontaneous Echocardiographic Contrast in the Internal Jugular Vein: Is It Useful and Does It Have Clinical Relevance?/ M. Spring, R. Parikh, J. Weinberg, C.L. Campbell Reardon, H.W. Farber, Boston, MA, p.A6792 P994 Validation of Estimated Cardiac Output Measured During CPET in Patients with Unexplained Dyspnea/ M. Alotaibi, S.C. Berngard, T.A. Morris, T. Fernandes, San Diego, CA, p.A6793 P995 Cardiopulmonary Reserve Index as Predictor of Survival in Patients with Pulmonary Hypertension Due to Left Heart Disease/ I. Shafran, C. Gerges, M. Gerges, M. Segel, I.M. Lang, Vienna, Austria, p.A6794 P996 Coronary Artery Plaque Burden in Patients with Pulmonary Arterial Hypertension/ K. Hersi, N. Kheda, B. Harper, G. Graninger, J.R. Matta, K.Z. Abd-Elmoniem, J. Sun, A. Gharib, M.A. Solomon, J.M. Elinoff, Bethesda, MD, p.A6795 P997 Forearm Microvascular Dysfunction in Patients with Scleroderma Pulmonary Hypertension/ A. Almoushref, T. Naal, K.S. Aulak, S. Chatterjee, K.B. Highland, R.A. Dweik, A.R. Tonelli, Cleveland, OH, p.A6796 P998 Different Prognostic Implications of Cardiac Index and Mixed Venous Oxygen Saturation in Idiopathic and Heritable Pulmonary Arterial Hypertension/ A. Almoushref, T. Naal, B. Abuhalimeh, R.A. Dweik, G.A. Heresi, A.R. Tonelli, Cleveland, OH, p.A6797 P999 Rest ETCO2 and Ve/VCO2 Are Superior to Exercise Gas Exchange Parameters with Invasive Cardiopulmonary Exercise Testing to Predict Pulmonary Vasc Disease in Patients with Dyspnea of Unclear Etiology/ F. Raza, A. Vaidya, P. Forfia, Madison, WI, p.A6798 Facilitator : R.F. Machado, MD, Indianapolis, IN P1000 Altered Hemodynamic Parameters Induced by Acute Vasoreactivity Testing Predict Outcome in Idiopathic Pulmonary Hypertension// S. Gong, P. Yuan, Y.-L. Yang, Q.-H. Zhao, R. Jiang, L. Wang, W.-H. Wu, J. Liu, Shanghai, China, p.A6799 P1001 Acute Pulmonary Vasoreactivity Testing Predicts Outcome in Idiopathic Pulmonary Hypertension with BMPR2 Mutation/ S. Gong, P. Yuan, J. Liu, Shanghai, China, p.A6800 P1002 Exercise Parameters Predict the Development of Scleroderma-Associated Pulmonary Arterial Hypertension/ N. Vasilottos, D. Khanna, V.V. McLaughlin, S.H. Visovatti, Ann Arbor, MI, p.A6801 P1003 High-Resolution CT Scan (HRCT) Measurements of Pulmonary Artery (PA) Dimensions Poorly Predict Pulmonary Hypertension (PH)/ P. Ratanawatkul, J.C. Richards, A.S. Oh, J. Swigris, Khon Kaen, Thailand, p.A6802 ATS 2019 • Dallas, TX 358 WEDNESDAY • MAY 22